Document Detail

Effect of antispastic agents (calcium antagonists and/or isosorbide dinitrate) on high-sensitivity C-reactive protein in patients with coronary vasospastic angina pectoris and no hemodynamically significant coronary artery disease.
MedLine Citation:
PMID:  15619396     Owner:  NLM     Status:  MEDLINE    
Levels of high-sensitivity C-reactive protein were measured before and after 3 months of treatment with antispastic agents (calcium antagonists and/or isosorbide dinitrate) in 27 patients who had coronary vasospastic angina pectoris and no hemodynamically significant coronary artery disease. Levels of high-sensitivity C-reactive protein decreased after treatment with antispastic agents.
Ming-Jui Hung; Wen-Jin Cherng; Chi-Wen Cheng; Ning-I Yang
Related Documents :
21540816 - Use of a hanging weight system for coronary artery occlusion in mice.
9326986 - The natural history of aneurysmal coronary artery disease.
12706756 - Association between air pollution and ischemic cardiovascular emergency room visits.
1858626 - Heart rate response during exercise testing and ambulatory ecg monitoring in patients w...
21821526 - Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to ad...
11993786 - Prognostic significance of the number of leads with st depression during an anginal att...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of cardiology     Volume:  95     ISSN:  0002-9149     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2005 Jan 
Date Detail:
Created Date:  2004-12-27     Completed Date:  2005-02-22     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  84-7     Citation Subset:  AIM; IM    
Cardiology Section, Department of Medicine, Chang Gung Memorial Hospital at Keelung, Keelung, Taiwan. <>
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angina Pectoris / drug therapy*,  etiology,  physiopathology*
C-Reactive Protein / drug effects*
Calcium Channel Blockers / pharmacology*,  therapeutic use
Coronary Disease / complications,  physiopathology
Coronary Vasospasm / complications,  drug therapy*
Isosorbide Dinitrate / pharmacology*,  therapeutic use
Middle Aged
Parasympatholytics / pharmacology*,  therapeutic use
Reg. No./Substance:
0/Calcium Channel Blockers; 0/Parasympatholytics; 87-33-2/Isosorbide Dinitrate; 9007-41-4/C-Reactive Protein
Comment In:
Am J Cardiol. 2005 Dec 1;96(11):1612   [PMID:  16310451 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Clinical characteristics of hypotension in patients with acute aortic dissection.
Next Document:  Usefulness of C-reactive protein as an independent predictor of death in patients with ischemic card...